Genenta Science SPA
NASDAQ:SAEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Genenta Science SPA.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Genenta Science SPA Does
Genenta Science is a biotechnology company that develops gene therapy treatments for cancer. Its main idea is to take a patient’s blood-forming stem cells, modify them in the lab, and use them to deliver anti-tumor signals inside the body. The company’s lead work is centered on Temferon, a platform designed to help the immune system attack solid tumors from within the tumor environment.
- Headquarters
- Italy IT
- Employees
- 9
- IPO date
- Dec 15, 2021
Earnings Waterfall
Genenta Science SPA
Continue SAEN Research
Decided on Genenta Science? Get an email when SAEN reaches the price you’d buy at. Free with an account.